DE2122529C2 - - Google Patents

Info

Publication number
DE2122529C2
DE2122529C2 DE2122529A DE2122529A DE2122529C2 DE 2122529 C2 DE2122529 C2 DE 2122529C2 DE 2122529 A DE2122529 A DE 2122529A DE 2122529 A DE2122529 A DE 2122529A DE 2122529 C2 DE2122529 C2 DE 2122529C2
Authority
DE
Germany
Prior art keywords
compounds
nucleoside
compound
disulfide
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE2122529A
Other languages
German (de)
English (en)
Other versions
DE2122529A1 (de
Inventor
Fritz Dr. Eckstein
Roger Sidney Dr. 3400 Goettingen De Goody
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Max Planck Gesellschaft zur Foerderung der Wissenschaften eV
Original Assignee
Max Planck Gesellschaft zur Foerderung der Wissenschaften eV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Max Planck Gesellschaft zur Foerderung der Wissenschaften eV filed Critical Max Planck Gesellschaft zur Foerderung der Wissenschaften eV
Priority to DE19712122529 priority Critical patent/DE2122529A1/de
Priority to GB1812172A priority patent/GB1328609A/en
Priority to IL39338A priority patent/IL39338A/xx
Priority to US00249579A priority patent/US3846402A/en
Priority to JP4418072A priority patent/JPS5640160B1/ja
Priority to HUPA1132A priority patent/HU168968B/hu
Priority to FR727216268A priority patent/FR2135669B1/fr
Priority to NLAANVRAGE7206144,A priority patent/NL178599C/xx
Priority to SU1781921A priority patent/SU437288A1/ru
Publication of DE2122529A1 publication Critical patent/DE2122529A1/de
Application granted granted Critical
Publication of DE2122529C2 publication Critical patent/DE2122529C2/de
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE19712122529 1971-05-06 1971-05-06 Thiophosphatanaloge der Nucleosid di und tnphosphate sowie Verfahren zu ihrer Herstellung Granted DE2122529A1 (de)

Priority Applications (9)

Application Number Priority Date Filing Date Title
DE19712122529 DE2122529A1 (de) 1971-05-06 1971-05-06 Thiophosphatanaloge der Nucleosid di und tnphosphate sowie Verfahren zu ihrer Herstellung
GB1812172A GB1328609A (en) 1971-05-06 1972-04-19 Thiophosphate analogues of nucleoside di-and triphosphates
US00249579A US3846402A (en) 1971-05-06 1972-05-02 Thiophosphate analogues of the nucleoside diphosphates and triphosphates and a method for the preparation thereof
JP4418072A JPS5640160B1 (enExample) 1971-05-06 1972-05-02
IL39338A IL39338A (en) 1971-05-06 1972-05-02 Thiophosphate analogues of the nucleoside diphosphates and triphosphates and processes for their preparation
HUPA1132A HU168968B (enExample) 1971-05-06 1972-05-05
FR727216268A FR2135669B1 (enExample) 1971-05-06 1972-05-05
NLAANVRAGE7206144,A NL178599C (nl) 1971-05-06 1972-05-05 Werkwijze voor de bereiding van zwavelhoudende nucleoside-derivaten.
SU1781921A SU437288A1 (ru) 1972-05-06 Способ получени тиофосфатных аналогов нуклеозид-ди-или -трифосфатов

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19712122529 DE2122529A1 (de) 1971-05-06 1971-05-06 Thiophosphatanaloge der Nucleosid di und tnphosphate sowie Verfahren zu ihrer Herstellung

Publications (2)

Publication Number Publication Date
DE2122529A1 DE2122529A1 (de) 1972-12-14
DE2122529C2 true DE2122529C2 (enExample) 1987-10-01

Family

ID=5807102

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19712122529 Granted DE2122529A1 (de) 1971-05-06 1971-05-06 Thiophosphatanaloge der Nucleosid di und tnphosphate sowie Verfahren zu ihrer Herstellung

Country Status (8)

Country Link
US (1) US3846402A (enExample)
JP (1) JPS5640160B1 (enExample)
DE (1) DE2122529A1 (enExample)
FR (1) FR2135669B1 (enExample)
GB (1) GB1328609A (enExample)
HU (1) HU168968B (enExample)
IL (1) IL39338A (enExample)
NL (1) NL178599C (enExample)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4728730A (en) * 1984-09-12 1988-03-01 Wisconsin Alumini Research Foundation Synthesis of nucleoside thiophosphoanhydrides
US4808708A (en) * 1985-11-02 1989-02-28 Toagosei Chemical Industry Co., Ltd. Phosphorsulfide derivatives of deoxynucleosides or deoxynucleotides and their uses
US5218103A (en) * 1988-05-26 1993-06-08 University Patents, Inc. Nucleoside thiophosphoramidites
US5750666A (en) * 1988-05-26 1998-05-12 Competitve Technologies, Inc. Polynucleotide phosphorodithioate compounds
US5278302A (en) * 1988-05-26 1994-01-11 University Patents, Inc. Polynucleotide phosphorodithioates
IL90359A0 (en) * 1988-05-26 1989-12-15 University Patents Inc Nucleoside and polynucleotide thiophosphoramidite and phosphorodithioate compounds and their production
US5602244A (en) * 1988-05-26 1997-02-11 Competitive Technologies, Inc. Polynucleotide phosphorodithioate compounds
US5216141A (en) * 1988-06-06 1993-06-01 Benner Steven A Oligonucleotide analogs containing sulfur linkages
WO1990012022A1 (en) * 1989-03-31 1990-10-18 University Patents, Inc. Polynucleotide phosphorodithioates as therapeutic agents for retroviral infections
AU6603690A (en) * 1989-10-05 1991-04-28 University Patents Inc. Nucleoside and polynucleotide thiophosphoramidite and phosphorodithioate compounds and processes
US5635488A (en) * 1991-10-15 1997-06-03 Isis Pharmaceuticals, Inc. Compounds having phosphorodithioate linkages of high chiral purity
US6060592A (en) * 1990-01-11 2000-05-09 Isis Pharmaceuticals, Inc. Pyrimidine nucleoside compounds and oligonucleoside compounds containing same
US5212295A (en) * 1990-01-11 1993-05-18 Isis Pharmaceuticals Monomers for preparation of oligonucleotides having chiral phosphorus linkages
US5587361A (en) * 1991-10-15 1996-12-24 Isis Pharmaceuticals, Inc. Oligonucleotides having phosphorothioate linkages of high chiral purity
US6339066B1 (en) 1990-01-11 2002-01-15 Isis Pharmaceuticals, Inc. Antisense oligonucleotides which have phosphorothioate linkages of high chiral purity and which modulate βI, βII, γ, δ, Ε, ζ and η isoforms of human protein kinase C
US5620963A (en) * 1991-10-15 1997-04-15 Isis Pharmaceuticals, Inc. Oligonucleotides for modulating protein kinase C having phosphorothioate linkages of high chiral purity
US5359052A (en) * 1991-08-05 1994-10-25 Polish Academy Of Sciences Chalcophospholanes useful in the synthesis of oligonucleoside phosphorothioates, phosphorodithioates and related selenates
US5646267A (en) * 1991-08-05 1997-07-08 Polish Academy Of Sciences Method of making oligonucleotides and oligonucleotide analogs using phospholanes and enantiomerically resolved phospholane analogues
US5599797A (en) * 1991-10-15 1997-02-04 Isis Pharmaceuticals, Inc. Oligonucleotides having phosphorothioate linkages of high chiral purity
US5576302A (en) * 1991-10-15 1996-11-19 Isis Pharmaceuticals, Inc. Oligonucleotides for modulating hepatitis C virus having phosphorothioate linkages of high chiral purity
US5654284A (en) * 1991-10-15 1997-08-05 Isis Pharmaceuticals, Inc. Oligonucleotides for modulating RAF kinase having phosphorothioate linkages of high chiral purity
US5607923A (en) * 1991-10-15 1997-03-04 Isis Pharmaceuticals, Inc. Oligonucleotides for modulating cytomegalovirus having phosphorothioate linkages of high chiral purity
US5661134A (en) * 1991-10-15 1997-08-26 Isis Pharmaceuticals, Inc. Oligonucleotides for modulating Ha-ras or Ki-ras having phosphorothioate linkages of high chiral purity
US6537973B1 (en) 1992-03-16 2003-03-25 Isis Pharmaceuticals, Inc. Oligonucleotide inhibition of protein kinase C
US5750341A (en) * 1995-04-17 1998-05-12 Lynx Therapeutics, Inc. DNA sequencing by parallel oligonucleotide extensions
WO1998018430A2 (en) * 1996-10-30 1998-05-07 The University Of North Carolina At Chapel Hill P2y receptor antagonists
US6159952A (en) * 1996-11-07 2000-12-12 Inspire Pharmaceuticals, Inc. Method of treating bronchitis with uridine triphosphate and related compounds
AU9124998A (en) * 1997-08-29 1999-03-16 Inspire Pharmaceuticals Use of uridine 5'-diphosphate and analogs thereof for the treatment of lung iseases
US6303774B1 (en) 1999-08-20 2001-10-16 Sri International Nucleoside pyrophosphate and triphosphate analogs and related compounds
US6864243B1 (en) 2000-05-12 2005-03-08 Inspire Pharmaceuticals, Inc. Method for treating retinal degeneration with purinergic receptor agonists
US7105962B2 (en) * 2000-08-03 2006-09-12 Matsushita Electric Industrial Co., Ltd. Brushless motor for partable electronic equipment with wire treatment technique of coils
EP1485395A4 (en) 2002-02-28 2011-04-13 Biota Scient Management NUCLEOTIDE MIMETICS AND PRODRUGS THEREOF
US7437892B2 (en) 2004-04-21 2008-10-21 Ppg Industries Ohio, Inc. Apparatus having vacuum applying facilities and method of using vacuum to bend and/or shape one or more sheets
US8618074B2 (en) * 2007-03-15 2013-12-31 Board Of Regents Of The University Of Texas System GPCR enhanced neuroprotection to treat brain injury
AU2014305843B2 (en) 2013-08-09 2019-08-29 Ardelyx, Inc. Compounds and methods for inhibiting phosphate transport
US9119832B2 (en) 2014-02-05 2015-09-01 The Regents Of The University Of California Methods of treating mild brain injury
WO2017075535A1 (en) 2015-10-28 2017-05-04 Oxeia Biopharmaceuticals, Inc. Methods of treating neurodegenerative conditions
KR102851054B1 (ko) * 2025-04-03 2025-08-26 김재혁 자연스러운 턱 움직임을 갖는 강아지 형상 로봇

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1227292A (enExample) * 1968-04-11 1971-04-07
US3687808A (en) * 1969-08-14 1972-08-29 Univ Leland Stanford Junior Synthetic polynucleotides

Also Published As

Publication number Publication date
NL178599B (nl) 1985-11-18
NL178599C (nl) 1986-04-16
IL39338A (en) 1975-08-31
SU437288A3 (ru) 1974-07-25
FR2135669A1 (enExample) 1972-12-22
NL7206144A (enExample) 1972-11-08
DE2122529A1 (de) 1972-12-14
HU168968B (enExample) 1976-08-28
JPS5640160B1 (enExample) 1981-09-18
IL39338A0 (en) 1972-07-26
GB1328609A (en) 1973-08-30
FR2135669B1 (enExample) 1973-07-13
US3846402A (en) 1974-11-05

Similar Documents

Publication Publication Date Title
DE2122529C2 (enExample)
EP0212536B1 (de) 7-Desaza-2'-desoxyguanosin-nukleotide, Verfahren zu deren Herstellung und deren Verwendung zur Nukleinsäure-Sequenzierung
DE60034354T2 (de) Verbindungen zum schutz von hydroxylgruppen und ihre anwendung
US3321463A (en) Process for the preparation of nucleoside-5'-polyphosphates and alpha, omega-bis-(nucleoside-5') polyphosphates
EP0600965B1 (de) Primer für matrizenabhängige enzymatische nukleinsäuresynthesen
US5795756A (en) Method and compounds for the inhibition of adenylyl cyclase
DE2628202A1 (de) Verfahren zur herstellung von 2'-substituierten-d-ribofuranosylpurinderivaten
DE3543346C2 (de) Verfahren zur Herstellung von Nucleosidkonjugaten
DE1695303A1 (de) Verfahren zur Herstellung von Nucleosid-5'-diphosphaten und -triphosphaten sowie Mono- und Oligonucleotidylnuclesid-5'-diphosphaten und triphosphaten
EP0927180A1 (de) Heterocyclische verbindungen und deren verwendung in der detektion von nucleinsäuren
Drummond et al. Deoxyribonucleoside-3′, 5′ Cyclic Phosphates. Synthesis and Acid-Catalyzed and Enzymic Hydrolysis
DE1918282A1 (de) Verfahren zur Herstellung von Diestern kondensierter Phosphorsaeure
DE3871778T2 (de) Kuenstliche analogen der dns-basenpaare.
DE69416860T2 (de) Nucleosideanaloge verfahren
US3701772A (en) Production of nucleotide anhydrides
DE2041735A1 (de) Thio-pyrimidin-derivate
DD140254A1 (de) Verfahren zur herstellung von 4-substituierten pyrimidin-nucleosiden
Takaku et al. A combined use of triphenyl phosphite and 2, 2′-dipyridyl diselenide as a coupling reagent in oligonucleotide synthesis
DE3328938T1 (de) Mittel und Verfahren zur Herstellung von A↑5↑↑'↑p↑5↑↑'↑p↑n↑↑3↑↑'↑p (AppNp)
DE2626792A1 (de) Acylderivate von adenosin-5'-monophosphorsaeure, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzung
UEDA et al. Nucleosides and Nucleotides. X. Synthesis of 4-Thiouracil Nucleosides and Nucleotides by the Solvolysis of Cytidine and Its Phosphates with Hydrogen Sulfide
EP0121112A1 (de) 2'-Desoxy-3'-phosphonylmethyl-nucleoside und Herstellungsverfahren
WO1993011144A1 (de) Neues verfahren zur herstellung von 2-fluorpurin-derivaten
DE69503994T2 (de) Verfahren zur herstellung von sialinsäure-derivaten und neue sialinsäure-derivate
DE3802367A1 (de) Verfahren zur synthese von nucleosid-5'-0-(1-thiotriphosphaten) (ntp(alpha)s) und 2'-deoxynucleosid-5'-0-(1-thiotriphosphaten) (dntp(alpha)s)

Legal Events

Date Code Title Description
OD Request for examination
D2 Grant after examination
8364 No opposition during term of opposition